These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3042355)

  • 21. Urapidil. A reappraisal of its use in the management of hypertension.
    Dooley M; Goa KL
    Drugs; 1998 Nov; 56(5):929-55. PubMed ID: 9829161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative trials of terazosin with other antihypertensive agents.
    Ruoff G
    Am J Med; 1986 May; 80(5B):42-8. PubMed ID: 2872806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized multicenter double-blind comparison of urapidil and ketanserin in hypertensive patients after coronary artery surgery.
    van der Stroom JG; van Wezel HB; Langemeijer JJ; Korsten HH; Kooyman J; van der Starre PJ; Kal JE; Porsius M; van den Ende R; van Zwieten PA
    J Cardiothorac Vasc Anesth; 1997 Oct; 11(6):729-36. PubMed ID: 9327314
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, controlled, multicenter study to compare prazosin GITS with enalapril in hypertensive patients with diabetes mellitus. Bombay Hypertension Study Group.
    Joglekar SJ; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():52-62. PubMed ID: 11233387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urapidil treatment decreases plasma fibrinogen concentration in essential hypertension.
    Haenni A; Lithell H
    Metabolism; 1996 Oct; 45(10):1221-9. PubMed ID: 8843176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evaluation of urapidil, a new antihypertensive drug: preliminary findings in Japan.
    Taniguchi K; Nakamura S; Iesaka Y; Nitta M; Ito H; Kirigaya H; Takeuchi J; Fujiwara H; Iizumi T; Inada M
    Clin Ther; 1985; 7(5):559-67. PubMed ID: 4053145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urapidil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of hypertension.
    Langtry HD; Mammen GJ; Sorkin EM
    Drugs; 1989 Dec; 38(6):900-40. PubMed ID: 2693046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind studies of the clinical effectiveness of prazosin.
    Schnaper HW; Oberman A
    Postgrad Med; 1975 Nov; Spec No():81-7. PubMed ID: 1105489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive efficacy of urapidil versus hydrochlorothiazide alone in patients with mild to moderate essential hypertension and of their combination in nonresponders to monotherapy.
    Fariello R; Dal Palu C; Pessina A; Semplicini A; Pirrelli A; Vulpis V; Carretta R; Bellini G; Buoninconti R; Wurst W
    Drugs; 1990; 40 Suppl 4():60-2. PubMed ID: 2092970
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute effects of increasing doses of urapidil in patients with hypertension.
    Culbertson VL; Bryant PJ; Cady WJ; Rubison RM; Piepho RW; Nies AS; Byyny RL
    Clin Pharmacol Ther; 1986 Jun; 39(6):690-6. PubMed ID: 3519043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the hemodynamic effects of urapidil, prazosin, and clonidine in healthy volunteers.
    Moore N; Fresel J; Joannidès R; Compagnon P; Thuillez C
    Blood Press Suppl; 1994; 4():7-12. PubMed ID: 7804515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urapidil in hypercholesterolemic hypertensive patients.
    Ferrara LA; Leonetti G; Fogari R; Mazzola C; Mancini M; Zanchetti A
    Blood Press Suppl; 1994; 4():39-44. PubMed ID: 7804511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of urapidil therapy on hemodynamics and gas exchange in exercising patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Adnot S; Andrivet P; Piquet J; Brun-Buisson C; Rauss A; Bignon J; Lemaire F
    Am Rev Respir Dis; 1988 May; 137(5):1068-74. PubMed ID: 3143277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of prazosin in 20 private practice patients.
    Maher PH
    Postgrad Med; 1975 Nov; Spec No():107-14. PubMed ID: 1105483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The antihypertensive effect of pinacidil versus prazosin in mild to moderate hypertensive patients seen in general practice.
    Sterndorff B; Johansen P
    Acta Med Scand; 1988; 224(4):329-36. PubMed ID: 3188983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the efficacy and tolerability of combination therapy with candesartan cilexetil and amlodipine besilate compared with candesartan cilexetil monotherapy and amlodipine besilate monotherapy in Japanese patients with mild-to-moderate essential hypertension: a multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Rakugi H; Ogihara T; Miyata Y; Sasai K; Totsuka N
    Clin Ther; 2012 Apr; 34(4):838-48. PubMed ID: 22440192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A long-term clinical trial of prazosin.
    Bradley WF
    Postgrad Med; 1975 Nov; Spec No():95-9. PubMed ID: 1105491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the antihypertensive effect of urapidil and metoprolol in hypertension.
    Leonetti G; Mazzola C; Boni S; Guffanti E; Meani A; Zanchetti A
    Eur J Clin Pharmacol; 1986; 30(6):637-40. PubMed ID: 3533561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Verapamil and prazosin in essential hypertension: evidence of a synergistic combination?
    Elliott HL; Meredith PA; Reid JL
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S108-10. PubMed ID: 2455106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orthostatic hypotension: how to avoid it during antihypertensive therapy.
    Rieckert H
    Am J Hypertens; 1996 Nov; 9(11):155S-159S. PubMed ID: 8931848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.